Rozanolixizumab Uses, Dosage, Side Effects and more
Rozanolixizumab is under investigation in clinical trial NCT03861481 (A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy).
| Attribute | Details |
|---|---|
| Trade Name | Rozanolixizumab |
| Generic | Rozanolixizumab |
| Rozanolixizumab Other Names | Rozanolixizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
